Glial cells in alzheimer’s disease: Preferential effect of apoe risk on scattered microglia

Gerontology

Volumn 43, Issue 1-2, 1997, Pages 109-118

  Saitoh, Tsunao ^a   Kang, David ^a   Mallory, Margaret ^a   De Teresa, Richard ^a   Masliah, Eliezer ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer s disease; Apolipoprotein E; Astrocyte; Gliosis; Microglia; Neuritic plaque

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENETIC RISK; GLIA CELL; HUMAN; HUMAN TISSUE; MICROGLIA; NEURITE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; ASTROCYTES; CELL COUNT; GLIOSIS; HUMANS; MICROGLIA; NEUROFIBRILLARY TANGLES; NEURONS; RISK FACTORS;

EID: 0031031311     PISSN: 0304324X     EISSN: 14230003     Source Type: Journal    
DOI: 10.1159/000213839     Document Type: Article

References (45)

1. Abraham C, Selkoe D, Potter H: Immunochemical identification of the serine protcase inhibitor alpha anti-chyniotrvpsin in the brain amyloid deposits of Alzheimer’s disease. Cell 1988;52:487-501.
2. Snow A, Sekiguchi R, Nochlin D, Kalaria R, Kimata K: Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain. Am J Pathol 1994:144:337-347.
3. Namba Y, Tomonaga M, Kawasaki H, Otonio E, Ikeda K: Apolipopro-tcin E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutz-fcldt-Jakob disease. Brain Res 1991: 541:163-166.
4. Ghiso J, Matsubara E, Koudinov A, Choi-Miura N, Tomita M, Wisniewski T, Frangione B: The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40.40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex. J Biochem 1993:293:27-30.
5. Griffin W, Sheng J, Roberts G, Mrak R: Interleukin-1 expression in different plaque types in Alzheimer's disease: Significance in plaque evolution. J Neuropathol Exp Neurol 1995:54:276-281.
6. Hucll M, Strauss S, Volk B, Berger M, Bauer J: Intcrleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients. Acta Neuropathol 1995:89:544-551.
7. Rozemuller J, Stam F, Eikclenboom P: Acute phase proteins are present in amorphous plaques in the cerebral but not in the cerebellar cortex of patients with Alzheimer’s disease. Neuro sci Lett 1990:119:75-78.
8. Eikelenboom P, Zhan SS, van Gool WA, Allsop D: Inflammatory mechanisms in Alzheimer’s disease. Trends Pharm Sci 1994; 15:447-450.
9. Dickson D, Lee S, Mattiace L, Yen S, Brosnan C: Microglia and cytokines in neurological disease. with special reference to AIDS and Alzheimer’s disease. Glia 1993:7:75-83.
10. McGecr PL, Kawamata T, Walker DG, Akiyama H, Tooyama I, McGeer F.G: Microglia in degenerative neurological disease. Glia 1993: 7:84-92.
11. David S, Bouchard C, Tsatas O, Gif-tochristos N: Macrophages can modify the nonpermissive nature of the adult mammalial central nervous system. Neuron 1990:5:463-469.
12. Hama T, Miyamoto M, Tsukui H, Nishio C, Hatanaka H: Intcrleukin-6 as a ncurotrophic factor for promoting the survival of cultured basal forebrain cholinergic neurons from postnatal rats. Neuro sci Lett 1989: 104:340-344.
13. Lindholm D, Hcumann R, Meyer M, Thocncn H: Interleukin-1 regulated synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature 1987:330:658-659.
14. Roses A: Apolipoprotein E genotyp-ing in the differential diagnosis, not prediction, of Alzheimer's disease. Ann Neurol 1995:38:6-14.
15. Ma J, Yee A, Brewer HB JR, Das S, Potter H: Amyloid-associated proteins α1-antichymotrypsin and apo-lipoprotcin E promote assembly of Alzheimer β-protein into filamentS, Nature 1994:372:92-94.
16. Strittmattcr W, Saunders A, Schme-chel D, Pericak-Vance M, Enghild J, Salvesen G, Roses AD: Apolipoprotein E: High avidity binding to 13-amyloid and increased frequency of type 4 allele in late onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993:90:1977-1981.
17. Wisniewski T, Golabek A, Matsubara E, Ghiso J, Frangione B: Apolipo-protein E: Binding to soluble Alzheimer’s β-amvloid. Biochem Bio-phys Res Commun 1993:192:359-365.
18. Sanan DA, Wcisgraber KH, Russell SJ, Mahley RW, Huang D, Saunders A, Schmechel D, Wisniewski T, Frangione B, Roses AD: Apolipoprotein E associates with beta amyloid peptide of Alzheimer’s disease to form novel monofibrils: Isoform apoE4 associates more efficiently than apoE3. J Clin Invest 1994:2: 860-869.
19. Strittmattcr WJ, Wcisgraber KH, Goedert M, Saunders AM, Huang D, Corder F.H, Dong LM, Jakes R, Albert MJ, Gilbert JR, et al: Hypothesis: Microtubulc instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp Neurol 1994:125:163-171.
20. Nathan BP, BcIIosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE: Differential effects of apolipo-proleins E3 and E4 on neuronal growth in vitro. Science 1994:264: 850-852.
21. Meda L, Cassatella M, Szendrei G, Otvos JL, Baron P, Villalba M, Ferrari D, Rossi F: Activation of microglial cells by β-amyloid protein and interferony. Nature 1995:374:647-650.
22. Galasko D, Saitoh T, Xia Y, Thai L, Katzman R, Hill L, Hansen L: The apolipoprotein E allele epsilon 4 is overrepresented in patients with the Lewy body variant of Alzheimer’s disease. Neurology 1994:44:1950-1951.
23. Hansen LA, Masliah E, Galasko D, Terry RD: Plaque-only Alzheimer disease is usually the Lewy body variant, and vice versa. J Neuropathol Exp Neurol 1993:52:648-654.
24. Jorgensen O, Brooksband B, Balazs R: Neuronal plasticity and astrocytic reaction in Down syndrome and Alzheimer’s disease. J Neurol Sci 1990:98:63-79.
25. Masliah E, Mallory M, Hansen L, Alford M, Albright T, Terry R, Shapiro P, Sundsmo M, Saitoh T: Im-munorcactivitv of CD45, a protein phosphotyrosine phosphatase, in Alzheimer's disease. Acta Neuropathol 1991:83:12-20.
26. Leuba G, Kraftsik R: Visual cortex in Alzheimer’s disease: Occurrence of neuronal death and glial proliferatioN, and correlation with pathological hallmarks. Neurobiol Aging 1994;15:29-43.
27. Mackenzie I, HaoC, Munoz D: Role of microglia in senile plaque formation. Neurobiol Aging 1994; 16:797-804.
28. Shaffer L, Dorily M, Gupta-Bansal R, Frederickson R, Younkin S, Brundcn K: Amyloid p protein (Ap) removal by neuroglial cells in culture. Neurobiol Aging 1995; 16:737-745.
29. Rebeck GW, Reiter JS, Strickland DK, Hyman BT: Apolipoprotcin E in Alzheimer’s disease: Allelic variation and receptor interactions. Neuron 1993;11:575-580.
30. Schmcchel DE, Saunders AM, Strittmatter WJ, Crain WJ, Hulctte C, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD: Increased amyloid P-peptide deposition as a consequence of apolipoprotein E genotype in late-onset Alzheimer’s disease. Proc Nati Acad Sci USA 1993: 90:9649-9653.
31. Tooyama J, Kawamata T, Akiyama H, Moestrup S, Gliemann J, McGeer P: Immunohistochemical study of alpha-2-macroglobulin receptor in Alzheimer and control postmortem human brain. Mol Chem Neuropathol 1993:18:153-160.
32. Harrigan M, Kunkel D, Nguyen L, Malouf A: Beta amyloid is neurotoxic in hippocampal slice cultures. Neurobiol Aging 1995;16:779-789.
33. Giulian D, Haverkamp L, Li J, Kar-shin W, Yu J, Tom D, Li X, Kirkpatrick J: Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer’s brain. Neurochem Int 1995:27:119-137.
34. Mori N, Stein R, Anderson D: A cell type-preferred silencer clement that controls the neural-spccific expression of the SCGIO gene. Neuron 1990;4:583-594.
35. Gray C, Patel A: Regulation of beta-amyloid precursor protein isoform mRNAs by transforming growth factor-beta I and interleukin-1 beta in astrocytes. Brain Res 1993; 19: 251-256.
36. Flanders K, Lippa C, Smith T, Pollen D, Sporn M: Altered expression of transforming growth factor-p in Alzheimer’s disease. Neurology 1995;45:1561-1569.
37. Gotz B, Scholze A, Clement A, Joe-ster A, Schutte K, Wiggcr F, Frank R, Spiess E, Ekblom P, Faissner A: Tenascin-C contains distinct adhesive, anti-adhesive, and ncuritc outgrowth promoting sites for neurons. J Cell Biol 1996:132:681-699.
38. Canning D, McKeon R, DeWitt D, Perry G, Wujek J, Frederickson R, Silver J: β-Amyloid of Alzheimer's disease induces reactive gliosis that inhibits axonal outgrowth. Exp Neurol 1993:124:289-298.
39. Mattiace LA, Davies P, Yen SH, Dickson DW: Microglia in cerebellar plaques in Alzheimer’s disease. Acta Neuropathol 1990:80:493-498.
40. McGccr PL, Itagaki S, Akiyama H, McGeer EG: Rate of cell death in parkinsonism indicates active neu-ropathological process. Ann Neurol 1988;24:574-576.
41. Styrcn SD, Civin WH, Rogers J: Molecular, cellular, and pathologic characterization of HLA-DR immu-noreactivity in normal elderly and Alzheimer’s disease brain. Exp Neurol 1990;110:93-104.
42. Perlmuttcr LS, Scott SA, Barron E, Chui HC: MHC class Il-positivc microglia in human brain: Association with Alzheimer lesionS, J Neurosci Res 1992;33:549-558.
43. Breitner JC, Gau BA, Welsh KA, Plassman BL, McDonald WM, Helms MJ, Anthony JC: Inverse association of anti-inflammatory treatments and Alzheimer’s disease: Initial results of a co-twin control study. Neurology 1994;44:227-232.
44. Lucca U, Tettamanti M, Forloni G, Spagnoli A: Nonsteroidal anti-inflammatory drug use in Alzheimer's disease. Biol Psychiatry 1994:36: 854-856.
45. Rich JB, Rasmusson DX, Folstein MF, Carson KA, Kawas C, Brandt J: Nonsteroidal anti-inflammatory drugs in Alzheimer’s disease. Neurology 1995:45:51-55.